QA & Test Automation for Pharmaceuticals & Life Sciences

A flaky suite is worse than no suite. Once a team starts re-running failures to see if they pass, the tests have stopped providing information and started providing delay.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how qa & test automation has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is regulatory dossier assembly, usually integrated against QMS. We start from the constraint, not the capability, what the system must never do, who signs off, and what happens when it is wrong.

Deployed across regulated and unregulated sectors, with audit trails where the regulator expects them. We hand over with runbooks, tests and a team that knows how it works, not a dependency.